Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl H June

Showing results (171-180 of 460) with videos related to

Pageof 46
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 4, 2017
Absence of Replication-Competent Lentivirus in the Clinic: Analysis of Infused T Cell ProductsKenneth Cornetta, Lisa Duffy, Cameron J Turtle, et al.
Cancer Immunology Research|April 30, 2014
T cells expressing chimeric antigen receptors can cause anaphylaxis in humansMarcela V Maus, Andrew R Haas, Gregory L Beatty, et al.
Cancer Research|April 12, 2013
Enhanced effector responses in activated CD8+ T cells deficient in diacylglycerol kinasesMatthew J Riese, Liang-Chuan S Wang, Edmund K Moon, et al.
Genome Biology|January 19, 2019
iGUIDE: an improved pipeline for analyzing CRISPR cleavage specificityChristopher L Nobles, Shantan Reddy, January Salas-McKee, et al.
Cancer Discovery|June 4, 2017
Overcoming the Immunosuppressive Tumor Microenvironment of Hodgkin Lymphoma Using Chimeric Antigen Receptor T CellsMarco Ruella, Michael Klichinsky, Saad S Kenderian, et al.
Cancer Research|March 17, 2016
A Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid TumorsXiaojun Liu, Raghuveer Ranganathan, Shuguang Jiang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 5, 2009
Analysis of lentiviral vector integration in HIV+ study subjects receiving autologous infusions of gene modified CD4+ T cellsGary P Wang, Bruce L Levine, Gwendolyn K Binder, et al.
Cancer Research|February 15, 2024
Editor's Note: In Vivo Persistence, Tumor Localization, and Antitumor Activity of CAR-Engineered T Cells Is Enhanced by Costimulatory Signaling through CD137 (4-1BB)De-Gang Song, Qunrui Ye, Carmine Carpenito, et al.
Cancer Research|May 7, 2011
In vivo persistence, tumor localization, and antitumor activity of CAR-engineered T cells is enhanced by costimulatory signaling through CD137 (4-1BB)De-Gang Song, Qunrui Ye, Carmine Carpenito, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2004
Extensive replicative capacity of human central memory T cellsMarcela V Maus, Birgit Kovacs, William W Kwok, et al.
Pageof 46

Showing results (171-180 of 460) with videos related to

Sort By:
Pageof 46
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 4, 2017
Absence of Replication-Competent Lentivirus in the Clinic: Analysis of Infused T Cell ProductsKenneth Cornetta, Lisa Duffy, Cameron J Turtle, et al.
Cancer Immunology Research|April 30, 2014
T cells expressing chimeric antigen receptors can cause anaphylaxis in humansMarcela V Maus, Andrew R Haas, Gregory L Beatty, et al.
Cancer Research|April 12, 2013
Enhanced effector responses in activated CD8+ T cells deficient in diacylglycerol kinasesMatthew J Riese, Liang-Chuan S Wang, Edmund K Moon, et al.
Genome Biology|January 19, 2019
iGUIDE: an improved pipeline for analyzing CRISPR cleavage specificityChristopher L Nobles, Shantan Reddy, January Salas-McKee, et al.
Cancer Discovery|June 4, 2017
Overcoming the Immunosuppressive Tumor Microenvironment of Hodgkin Lymphoma Using Chimeric Antigen Receptor T CellsMarco Ruella, Michael Klichinsky, Saad S Kenderian, et al.
Cancer Research|March 17, 2016
A Chimeric Switch-Receptor Targeting PD1 Augments the Efficacy of Second-Generation CAR T Cells in Advanced Solid TumorsXiaojun Liu, Raghuveer Ranganathan, Shuguang Jiang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 5, 2009
Analysis of lentiviral vector integration in HIV+ study subjects receiving autologous infusions of gene modified CD4+ T cellsGary P Wang, Bruce L Levine, Gwendolyn K Binder, et al.
Cancer Research|February 15, 2024
Editor's Note: In Vivo Persistence, Tumor Localization, and Antitumor Activity of CAR-Engineered T Cells Is Enhanced by Costimulatory Signaling through CD137 (4-1BB)De-Gang Song, Qunrui Ye, Carmine Carpenito, et al.
Cancer Research|May 7, 2011
In vivo persistence, tumor localization, and antitumor activity of CAR-engineered T cells is enhanced by costimulatory signaling through CD137 (4-1BB)De-Gang Song, Qunrui Ye, Carmine Carpenito, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2004
Extensive replicative capacity of human central memory T cellsMarcela V Maus, Birgit Kovacs, William W Kwok, et al.
Pageof 46